12.600 Euro aus dem ASK - 150 % - 500 Beiträge pro Seite

[MCGabriel]

Habe heute morgen einen Thread zu MDGN eröffnet.

Nun ein Trade mit 42.000 Stücken vom Berliner Makler gekauft Plus 150 %.

Kann der nicht warten bis USA eöffnet oder sind das bereits die mis die auch in Berlin kaufen

Med Gen. Inc.
Skontroführer: MWB Wertpapierhandelshaus AG (1172)


Best Bid
Volumen Taxe
- 0,15

Kauf Orders
Stücke Limit
12.000 0,12
20.500 0,1
- -
- -
- -
Weitere: 0
Best Ask
Taxe Volumen
0,35 -

Verkauf Orders
Limit Stücke
0,25 12.000
0,27 5.000
0,35 5.000
- -
- -
Weitere: 0


ISIN: US58401X2099
WKN: A0CABE


Tagesübersicht
akt. Spread in %: 133,33
Letzter Preis: 0,3
Uhrzeit: 11:33:16
Umsatz (Stück): 42.000
Preise gesamt: 2
Umsatz gesamt: 42.000


Statistik
Tageshoch: 0,3
Tagestief: 0,1
Diff. in %: +150

Diff. abs.: +0,18

Eröffnungspreis: 0,1
Schluß Vortag: 0,12

[MCGabriel]

Mal sehen, ob er nochmal zuschlägt

[MCGabriel]

Vielleicht kann der in USA nicht kaufen und siehts langfristig

[MCGabriel]

Jetzt stehen 52k zu 0.25 im ASK - mal sehen ob er die sich auch holt

[MCGabriel]

Sieht schon geil aus - ab ca. 0.45 bricht es noch weiter aus

[MCGabriel]

Vielleicht auch deshalb

Update: September 14, 2004



To all shareholders:



I cannot foretell the future, nor can I change the past. However, you can surely bet that I will work hard to preserve what has been built over the past seven years. The news reports of the last few weeks can only portray a flash of our company, a short moment in time that becomes instant history. Still, I have done my best to convey the good and the bad, the bold and the serene, the positive and the negative While it is true that Med Gen is going through the undulating rigors of a post trial loss, you must be aware that the atmosphere, much to the credit of our staff, is one of business as usual.



The Justice system is at times unjust. I still smart over how the legitimate firing of our former distributors, which was due to the failed promise of millions of dollars in orders and the re-assigning of brokers to an alien company without a single notice, could have turned into this prolonged lawsuit. The legal costs of the trial alone exceeded $300,000. That a judgment award, made by a jury of six women (with little or no business experience) and one college aged man, could have awarded a judgment amount that is more than the entire profits gained from the one account that they claimed to have opened, is yet another example of a system gone awry.



Yet, I am told that there are safeguards built into the system and that is what we are now pursuing. Although I don’t believe in luck, I do believe in justice and I believe Med Gen will have its “day in court” and we will prevail. While this is going on we must take care of business. Recently the company has announced two major store openings, Meijers that has stores in Ohio, Wisconsin, Kentucky, Illinois and Gristedes, which is a “king” in the New York City area. There are several other important store openings that will be announced as they come on line. The goal is 40,000 outlets by the end of fiscal year 2005. As distribution increases our advertising budget will increase proportionately. Our recent advertising blitz featuring both TV and Radio commercials has proved to us the real power of advertising and how important it is to the success of any marketing program. The Rush Limbaugh Show was especially important to us.



As you also know, we have been pushing the international markets and we expect considerable activity from China and Europe. Time and money are the keys to success overseas. We have succeeded in winning our CE registration for the European Common Markets, TGF approval for Australia and KFDA approval for Korea… The process will continue and we should start shipping meaningful amounts into directed overseas markets as their stringent requirements are met. The process is not easy and it is costly, but the rewards are great.



Then there is the subject of our stock. As I read the chat room gossip I get the feeling of total confusion. It is largely true that stocks tend to positively react to buying support. However, it is undeniably true that in OTCBB stocks, the machinations by Market Makers, creating short positions and price fluctuations, have a great persuasion on the price. Day trading in “penny stocks” has become the game of choice for “chatters”. This too adds to the confusion of the markets and creates large swings. Yet, all agree that the greater persuasion towards the buy side and the result is a rapid upward trend. It is the very nature of Chat Rooms which create rapid buying and selling…. Not a good combination for long-term growth. Most “Chat Investors”, as I like to call them, cannot win as they rapidly move from one tout to another, selling and buying in a reckless manner. Do your homework! If you believe in our products, in our philosophy and in our management team, then take an initial position and add to it, averaging up or down as the case may be. Your investing results should certainly improve.



We are all equals as Shareholders. We are afloat in the same Ocean, all rising and falling with the waves together. It is not they and we… Only us, together. Why come out of this as a good company when we can be a great company. Med Gen does have this opportunity and I hope you can recognize this. After all, we are a company with great products, great distribution and great opportunities.



There is much to get done.



Respectfully,





Paul B. Kravitz

Chairman/CEO


Glaube mal daß die MM`s das Teil zu diesem niedrigen Kurs gebracht haben und sich nun langsam wieder eindecken müssen, weil sie erkennen, daß die nicht kaputt zu machen sind

[Strait1]

Schade MCG,

hatte Deinen Tip mal wieder als den üblichen Kram gewertet.

[Karin1507]

da hat einer bereits gestern 100K in Berlin zu überhöhtem Preis gekauft, bevor die Amis eröffnet haben, bevor das Ding gestern in USA abging........der hat es gewußt vielleicht weiß einer wieder etwas

[MCGabriel]

Ja Strait - so kanns gehen

[MCGabriel]

Möglich Karin alles möglich

Ich könnte fast wetten, er holt sich noch mehr. Er wartet nur ab, ob noch mehr Angebote kommen

[js200]

09/28/2004 (08:30 ET) Med Gen to Benefit from New York City Sales of Snorenz & Good Nights Sleep - Business Wire
09/17/2004 (18:54 ET) MDGN: Filed New Form 4 - Edgar
09/13/2004 (08:45 ET) MDGN: Lender Agreement to Fund International Expansion - Knobias
09/13/2004 (08:30 ET) Med Gen Inc. Files Motion for New Trial - Business Wire
09/01/2004 (08:00 ET) Med Gen Lender Agrees to Capitalize Expansion of International Markets - Business Wire

[js200]

Other new store openings will be announced shortly, both in the United States and abroad. Increasing gross sales to $2.5 million is our absolute minimum goal for our next fiscal year ending in September 2005 said Mr. Kravitz.


JS200

[js200]

09/29/2004 (07:01 ET) eLocity Inc.: Trading Watch Alerts Issued for: GLVP, ROCK, SSFT, MDGN - PrimeZone Media Network
09/28/2004 (08:30 ET) Med Gen to Benefit from New York City Sales of Snorenz & Good Nights Sleep - Business Wire
09/17/2004 (18:54 ET) MDGN: Filed New Form 4 - Edgar
09/13/2004 (08:45 ET) MDGN: Lender Agreement to Fund International Expansion - Knobias
09/13/2004 (08:30 ET) Med Gen Inc. Files Motion for New Trial - Business Wire

[Karin1507]

http://host.wallstreetcity.com/wsc2/Autoflag.html?Button=Get…

[MCGabriel]

Läuft doch wie geschmiert

[Vangogo]

Schaut euch mal den Chart an, von wo die herkommen.
Waren letztes Jahr noch bei 2USD.
All-Time-High vor 4 Jahren: über 30 USD

[Vangogo]

Hab mal bei 0,19 USD ein paar ins Depot gelegt.

Ich denke dass die Meldung von gestern bei weitem noch nicht honoriert wurde.

Greetingx
Vangogo

[Vangogo]

Schaut euch mal das Orderbuch an:

BID
HILL 0.170 50
NITE 0.170 50
TDCM 0.170 50
SEAB 0.170 50
MAXM 0.165 50
FRAN 0.160 50
PERT 0.160 50
SCHB 0.160 50

ASK
SCHB 0.185 50
NITE 0.190 50
BAMM 0.190 50
FRAN 0.195 50
PERT 0.195 50
MAXM 0.197 50
SEAB 0.210 50
TDCM 0.220 50


Aktie hat Morgengap bis 0,17 geschlossen, ab jetzt geht es wieder Richtung NORDEN

[js200]

bellwetherreport.com: BWR Issues Investor Alert for Med Gen Inc
via COMTEX

September 29, 2004

Sep 29, 2004 (M2 PRESSWIRE via COMTEX) --

The Bellwether Report, has begun researching Med Gen Inc (OTCBB:MDGN), a manufacturer of the national brands Snorenz(R),a snore relief throat spray and Good Nights Sleep(R), sleep-aid throat spray.

The company announced yesterday that it has received orders from Gristedes and Sloan`s Supermarkets, located in New York City, for both of their products.

The company is expected to benefit from the marketing campaign and advertising that they will receive, from the aggressive promotion set to kick off in large urban cities.

The Bellwether Report, will continue to track this company over the ensuing months, as they are expected to increase gross sales by $2.5 million by their next fiscal year end of September 2005.

If you would like all the corporate updates and developments for Med Gen Inc, feel free to visit www.bellwetherreport.com and sign up for a complimentary subscription to our online financial newsletter.

The Bellwether Report, will continue scanning the markets for true emerging growth opportunities that will show subscribers optimal entry points with profitable exit points. If you are interested in receiving more information on the above mentioned companies feel free to sign up for a 3 month complimentary subscription to the #1 online investment resource www.bellwetherreport.com.

All material herein was prepared by the Bellwetherreport.com , (Bellwether) based upon information believed to be reliable. The information contained herein is not guaranteed by Bellwether to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Bellwether is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. Bellwether may receive compensation in cash or shares from independent third parties or from the companies mentioned.

Bellwether`s affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. Market commentary provided by Jay Lee.

Bellwether will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies` annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.

You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and Bellwether undertakes no obligation to update such statements.

CONTACT: Tel: [phone]

M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to [e-mail].

(C)1994-2004 M2 COMMUNICATIONS LTD

Print story

Current Quote

OBB: MDGN
Last: 0.159
Change: N/A
Volume: 1,424,671
Day High: 0.210
Day Low: 0.155



First Alert News
Get real-time MDGN release alerts by entering your email address below.


JS200

[MCGabriel]

Kleine Gewinnmitnahmen sind normal und gesund

Es geht in den nächsten Wochen wieder stetig bergauf. Halt keine ockeraktie

[js200]

09/29/2004 (12:10 ET) bellwetherreport.com: BWR Issues Investor Alert for Med Gen Inc - M2 Communications
09/29/2004 (07:01 ET) eLocity Inc.: Trading Watch Alerts Issued for: GLVP, ROCK, SSFT, MDGN - PrimeZone Media Network
09/28/2004 (08:30 ET) Med Gen to Benefit from New York City Sales of Snorenz & Good Nights Sleep - Business Wire
09/17/2004 (18:54 ET) MDGN: Filed New Form 4 - Edgar
09/13/2004 (08:45 ET) MDGN: Lender Agreement to Fund International Expansion - Knobias

[7.Sinn]

@ all
der Makler in B. hat nicht nur eine Meise sondern auch Realitätsverlust.

[babe_in_the_woods]

Wieso stellt ihr kein Verkaufsorder von 0.3 EUR oder ein Kauforder von 0.1 EUR rein ?

[7.Sinn]

Kopiert vom RB Board

September 29, 2004

From the Chairman

AN OPEN LETTER TO ALL SHAREHOLDERS AND THE GENERAL PUBLIC

Nobody benefits when rumors dictate the movement of stock or the direction of a company. While it is true that most stocks trade on “future hope” and some hype, it is also true that the personality of a real company should be based upon fact, calculated predictions and honesty.

It is often said that life is shaped by events… and to a great degree I believe that there is truth to that adage. Med Gen is now seven years old. Most companies don’t make it past the three-year mark. So you must believe that we have great products, great management or both. We certainly never had the benefit of a lot of money. The biggest single event that is now shaping our destiny is the lawsuit that has been recently announced in a News Release by the company and which has been discussed ad nauseum in almost every chat room on the Internet.

Let me clarify for all, the future events that are apt to take place and the possible effects on our company. Mind you, the attitude of management is “business as usual”. You have been made aware of significant progress in marketing, distribution and R&D efforts to bring out new and exciting products. This massive effort on the part of management will no doubt make Med Gen an exciting and highly prosperous company. Yet we must get over the legal problems in order to build immediate shareholder loyalty and long-term investors.

With regard to the lawsuit, there are several events going on at the same time. There is a (i) “motion for a new trial”, (ii) negotiation for settlement, (iii) Appeal for a new trial on damage award and (iv) filing prepared for protection under the chapter 11 bankruptcy code. None of these events, other than a negotiated settlement, would happen before March 2005 and maybe, in the case of an Appeal until early 2006. The company’s legal team will protect us all during the process, leaving management free to run the company [not that I don’t worry a lot- and oversee the process]. The point is, to make a “buy” or “no buy” decision at this point purely on the speculative outcome of the legal action does not make much sense. As the gurus say, buy low sell high. If you as an investor feel that our stock at this level is undervalued, this could well be the buying opportunity of a lifetime.

Disclaimers aside, Snorenz® and Good Night’s Sleep® are products of unparallel value with huge market potential. Did you know that the combined domestic markets for these products exceed $1.6 billion? You should also know that Good Night’s Sleep is unique in that it has no competition as a liquid spray sleep-aid…Snorenz® has only one competitor and Snorenz® is the only all natural snore-relief brand, an original patented formula that has been proven over 7 years and major studies to do what it says it will do. We are a company with real products, sold in major stores throughout the USA and soon in major markets World-Wide. Need I say more!

[MCGabriel]

Die MM`s ziehen das Ding wieder runter - ist ja nicht zum Mitansehen

[Siffel]

bis die nächste news kommt, wird der kurs wahrscheinlich wieder kräftig brökeln. hier sind zu viele zocker am werk die sofort nach dem hype wieder ihre shares verticken.
Meine prognose: kurs fällt langsam aber sicher bis 0,10
bei der nächsten meldung geht es dann an einem tag wieder auf 0,3$. wir werden sehen

[ecos]

vieleicht heute mal anders niedriger Kurse und am Schluß nach oben, in US verkauft keiner unter 0,12 mehr. Das bid ist auch schon auf 0,12 angezogen.

[MCGabriel]

Na keiner mehr dabei

[Karin1507]

doch ich, kzrs zieht wieder an 0,185